| Trintellix (vortioxetine) / Lundbeck, Takeda |
NCT02559947: The Relationship Among Changes in Brain Network Activation in Adult Outpatients With Major Depressive Disorder |
|
|
| Not yet recruiting | 4 | 50 | US | Vortioxetine, Brintellix | Psychiatric Medicine Associates, L.L.C., Takeda Pharmaceuticals North America, Inc., ElMindA Ltd | Major Depressive Disorder | 10/17 | 10/18 | | |
| Active, not recruiting | 4 | 88 | US | Vortioxetine, Brintellix, Placebo | Northwell Health, Takeda | Schizophrenia, Negative Symptoms | 10/23 | 06/24 | | |
VENUS, NCT05104918: Vortioxetine as a Novel Anti-depressant With Improvement in Cognitive Abilities |
|
|
| Not yet recruiting | 3 | 500 | NA | Vortioxetine, VORSCOT tablets, Venlafaxine, Venlafexine | Scotmann Pharmaceuticals, Rawalpindi Medical College | Major Depressive Disorder | 04/22 | 06/22 | | |
NCT05417087: Single Dose Oral Bioequivalence Study of Vortioxetine Hemihydrobromide Orally Disintegrating Tablets |
|
|
| Completed | 1 | 48 | RoW | Vortioxetine Hemihydrobromide Orally Disintegrating Tablets, SF001 ODT, Vortioxetine Hydrobromide Tablets, Trintellix | Seasons Biotechnology (Taizhou) Co., Ltd. | Major Depressive Disorder (MDD) | 09/22 | 09/22 | | |
NCT05416957: Food Effect Bioavailability Study of Vortioxetine Hemihydrobromide Orally Disintegrating Tablets |
|
|
| Completed | 1 | 24 | RoW | Vortioxetine Hemihydrobromide Orally Disintegrating Tablets, SF001 ODT | Seasons Biotechnology (Taizhou) Co., Ltd. | Major Depressive Disorder (MDD) | 10/22 | 10/22 | | |
NCT05416762: Single Dose Study to Evaluate Dose-proportionality of Vortioxetine Hemihydrobromide Orally Disintegrating Tablets |
|
|
| Completed | 1 | 30 | RoW | Vortioxetine Hemihydrobromide Orally Disintegrating Tablets 5mg, SF001 ODT 5mg, Vortioxetine Hemihydrobromide Orally Disintegrating Tablets 10mg, SF001 ODT 10mg, Vortioxetine Hemihydrobromide Orally Disintegrating Tablets 20mg, SF001 ODT 20mg | Seasons Biotechnology (Taizhou) Co., Ltd. | Major Depressive Disorder (MDD | 11/22 | 11/22 | | |
NCT05932407: A Database Survey of Comparison The Risk of Haemorrhage Between Vortioxetine Tablet Treatment and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment in Participants With Depression |
|
|
| Not yet recruiting | N/A | 115000 | NA | Vortioxetine Tablet, TRINTELLIX Tablets, SSRI | Takeda | Major Depressive Disorder | 07/24 | 07/24 | | |